|
Osteotech, Inc. - Price Analysis Snapshot
This Report features up to a ten-year record of the equity Price history for Osteotech, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
Osteotech, Inc.. The Group's principal activities are processing of human bone and connective tissue technologies for transplants and developing, manufacturing, and marketing biologic, biomaterial and device systems for musculoskeletal surgery. It has four operating segments: Demineralized Bone Matrix (DBM), Traditional Tissue, Spinal Allograft, Client Services and Hybrid/Synthetics. The DBM Segment provides processing and marketing of 'Grafton' and private label 'Demineralized Bone Matrix.' The Tissue Segment provides processing of mineralized weight-bearing allograft bone tissue. Other business units provide marketing and distributing metal spinal implant products and processing, marketing and distributing bovine tissue products. Products and services are marketed primarily to the orthopaedic, spinal, neurological, oral/maxillofacial, dental and general surgery customers in the United States, Europe and Asia.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|